References
- George JN, Cuker A. Drug-induced thrombotic microangiopathy. In: UpToDate (Eds. Leung LLK, Tirnauer JS), Wolters Kluwer. www.uptodate.com/contents/drug-induced-thrombotic-microangiopathy. (Accessed on September 14, 2016.)
- Kulaksizoglu M, Gonen MS, Kebapcilar L, Sahin F, Acikgoz B, Demir T, Dincturk E. Multiorgan dysfunction accompanied with metimazole and thyroid storm. Transfus Apher Sci 46, 149–152, 2012.
- Mariotte E, Veyradier A. Thrombotic thrombocytopenic purpura: from diagnosis to therapy. Curr Opin Crit Care 21, 593–601, 2015.
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30, 239–245, 1981.
- Papi G, Corsello SM, Pontecorvi A. Clinical concepts on thyroid emergencies. Front Endocrinol (Lausanne) 5, 102, 2014.
- Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees S, Samuels M, Sosa JA, Stan MN, Walter M. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis. Thyroid 26, 1343–1421, 2016.
- Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiokowski ZM, Williams ME, Wu Y, Shaz BH. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 28, 145–284, 2013.